NASDAQ : PGNY
Progyny, Inc. — Key statistics
Healthcare · Healthcare Plans · United States
Last price 29.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.24B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.26B |
| Enterprise Value | 2.05B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 76.73M |
| Shares Outstanding | 76.73M |
| Shares Change (YoY) | -4.01% |
| Shares Change (QoQ) | -3.08% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 101.37% |
| Float | 70.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 32.42 |
| Forward PE | 13.45 |
| PS Ratio | 1.72 |
| Forward PS | 1.57 |
| PB Ratio | 4.98 |
| P/TBV Ratio | 5.28 |
| P/FCF Ratio | 12.65 |
| P/OCF Ratio | 11.21 |
| PEG Ratio | 1.16 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 26.03 |
| EV / Sales | 1.56 |
| EV / EBITDA | 16.30 |
| EV / EBIT | 17.08 |
| EV / FCF | 11.47 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.14 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 16.24% |
| Return on Assets (ROA) | 10.14% |
| Return on Invested Capital (ROIC) | 32.44% |
| Return on Capital Employed (ROCE) | 25.19% |
| Weighted Average Cost of Capital (WACC) | 9.35% |
| Revenue Per Employee | $1.53M |
| Profits Per Employee | $91,861 |
| Employee Count | 856 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 41.21M |
| Effective Tax Rate | 34.38% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +57.19% |
| 50-Day Moving Average | 26.95 |
| 200-Day Moving Average | 24.39 |
| Relative Strength Index (RSI) | 63.29 |
| Average Volume (20 Days) | 956,940 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.85M |
| Short Previous Month | 5.09M |
| Short % of Shares Out | 6.32% |
| Short % of Float | 6.90% |
| Short Ratio (days to cover) | 4.06 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.31B |
| Gross Profit | 322.09M |
| Operating Income | 119.83M |
| Pretax Income | 119.84M |
| Net Income | 78.63M |
| EBITDA | 125.57M |
| EBIT | 119.83M |
| Earnings Per Share (EPS) | $0.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 236.93M |
| Total Debt | 26.97M |
| Net Cash | 209.96M |
| Net Cash Per Share | $2.74 |
| Equity (Book Value) | 453.26M |
| Book Value Per Share | 5.90 |
| Working Capital | 272.93M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 201.25M |
| Capital Expenditures | -22.86M |
| Depreciation & Amortization | 5.74M |
| Net Borrowing | n/a |
| Free Cash Flow | 178.38M |
| FCF Per Share | $2.32 |
Margins
| Measure | Value |
|---|
| Gross Margin | 24.57% |
| Operating Margin | 9.14% |
| Pretax Margin | 9.14% |
| Profit Margin | 6.00% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 9.14% |
| FCF Margin | 13.61% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.01% |
| Shareholder Yield | 4.01% |
| Earnings Yield | 3.08% |
| FCF Yield | 7.91% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $34.42 |
| Price Target Difference | 17.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.95% |
| EPS Growth Forecast (3Y) | 10.29% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7.63 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |